BCRX

BCRX Operating Expenses

$534.75MTTM · USD

Period ending:

BCRX FY Operating ExpensesUSD
BCRX FY Operating Expenses1994-12-31: $2.50M1995-12-31: $2.80M1996-12-31: $3.20M1997-12-31: $13.90M1998-12-31: $12.90M1999-12-31: $11.10M2000-12-31: $13.15M2001-12-31: $16.14M2002-12-31: $18.33M2003-12-31: $14.33M2004-12-31: $22.09M2005-12-31: $27.33M2006-12-31: $53.19M2007-12-31: $103.52M2008-12-31: $83.73M2009-12-31: $83.78M2010-12-31: $96.65M2011-12-31: $69.23M2012-12-31: $58.29M2013-12-31: $47.95M2014-12-31: $59.26M2015-12-31: $85.81M2016-12-31: $72.26M2017-12-31: $80.90M2018-12-31: $114.40M2019-12-31: $144.19M2020-12-31: $190.89M2021-12-31: $327.63M2022-12-31: $412.67M2023-12-31: $430.46M2024-12-31: $440.77M2025-12-31: $514.77M$514.77M$0.00
1994-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BCRX operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 32 observations from Dec 31, 1994 to Dec 31, 2025.

Biocryst Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
514,773,000
440,770,000
430,460,000
412,668,000
327,626,000
190,893,000
144,189,000
114,402,000
80,895,000
72,261,000
85,805,000
59,257,000
47,950,000
58,290,000
69,230,000
96,652,000
83,783,000
83,725,861
103,517,958
53,191,745
27,328,700
22,088,767
14,334,000
18,329,295
16,143,146
13,147,608
11,100,000
12,900,000
13,900,000
3,200,000
2,800,000
2,500,000

Compare operating expenses

All BCRX financial metrics · BCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.